RE:RE:Great News!I am one of these "old investors" that you mentioned. Why would I sell any of my shares to exercise my warrants at this moment in time? The company has all of the data AND the algorithm key in their possession from the trials. This stock is about to jump to between $2 and $3 per share with the results, followed by $3 to $7 per share when Phase 3 is announced. They will be bought out for over $20 per share by a large Pharma company during Phase 3. I will exercise my warrants when Phase 3 begins, unless HEM accelerates them before that point in time. This is a terrible soft bash and is almost as bad as the one about study publishing timeframes. If you are a shorter, cover soon or you will lose everything. Good luck everyone! In my opinion only. Thanks-Buda.